Franz Murphy
Vascular Surgery · Kearney, NENPI 1194953059
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,045 of the $4,745 with a category attached, or 85.2%. 29 manufacturers reported payments, led by Endologix LLC at 30.7% of the total. That places this record below the midpoint for vascular surgery clinicians in NE, where the typical reported total is $4,193.
Across 85 payments — averaging $55.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$1K
- Medtronic$1K
- Abbott$406
- Musculoskeletal Transplant Foundation Inc.$266
- W. L. Gore & Associates, Inc.$258
- Inari Medical, Inc.$216
- plus $1K from 23 others
What the payments were for
- Travel & lodging$70015%
- Food & beverage$4,04585%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 12 | $1,454 |
| Medtronic | 15 | $1,142 |
| Abbott | 11 | $406 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $266 |
| W. L. Gore & Associates, Inc. | 3 | $258 |
| Inari Medical, Inc. | 4 | $216 |
| Cardiovascular Systems Inc. | 2 | $174 |
| Cook Medical LLC | 1 | $122 |
| Stryker | 3 | $117 |
| Johnson & Johnson | 9 | $114 |
| Integra Lifesciences Corporation | 2 | $77 |
| Organogenesis Inc. | 1 | $42 |
| Amgen | 2 | $38 |
| Bard Peripheral Vascular, Inc. | 2 | $33 |
| Lemaitre Vascular, Inc. | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Siemens Medical Solutions USA, Inc. | 1 | $25 |
| Polynovo North America LLC | 1 | $23 |
| Sanofi | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Solventum Corporation | 1 | $18 |
| Merck | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Pfizer | 1 | $17 |
| Angiodynamics, Inc. | 1 | $16 |
| Terumo Medical Corporation | 1 | $15 |
| Chiesi USA, Inc. | 1 | $15 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Abre$910
- AFX$746
- AFX2 Bifurcated Endograft System$230
- ESPRIT$144
- Diamondback Peripheral$141
- Diamondback Coronary$141
- VIABAHN Endoprosthesis$129
- Lunderquist$122
- Torus Stent Graft System$119
How this compares
$4,745 in reported general payments places this provider in the 50th percentile of 35 vascular surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 69 | $45,472 |
| Cilostazol | 24 | $503 |
| ClopidogrelClopidogrel Bisulfate | 76 | $453 |
| Diazepam | 20 | $15 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $114 | $45,47269 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 35 vascular surgery providers in Nebraska.
Other vascular surgery in Kearney
- John ParkOmaha$508K
- David VogelOmaha$41K
- Marcus BaltersOmaha$27K
- Anjan TalukdarOmaha$25K
- Iraklis PipinosOmaha$24K
- Rao GuttaOmaha$21K
- Sara HargreavesLincoln$17K
- Rommie HughesScottsbluff$15K
- Tammy RamosOmaha$10K
- Shradha SamuelLincoln$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.